Description
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
Tp40, GP40, LEU-9, CD7 molecule |
|
Species |
Human |
|
Expression Sequence |
Ala26-Pro180 |
|
Accession |
P09564 |
|
Tag |
C-hFc |
|
Expression System |
HEK293 |
|
Molecular Weight |
Predicted MW: 43.19 kDa. Due to glycosylation, the protein migrates to 55-70 kDa (SDS-PAGE). |
|
Purity |
>95% (SDS-PAGE & HPLC). |
|
Endotoxin |
<1.0 EU/μg (LAL method). |
|
Formulation |
Lyophilized from 0.22 μm filtered PBS (pH 7.4). 8% trehalose added as protectant. |
|
Appearance |
Lyophilized Powder |
|
Biological Activity |
【ELISA Data】 Immobilized Human CD7, hFc Tag at 0.5 μg/mL (100 μL/well). Dose response curve for Biotinylated Anti-CD7 Antibody with hFc Tag shows EC₅₀ = 27.7 ng/mL. |
|
Reconstitution Method |
Centrifuge briefly before opening. Reconstitute with distilled water to >100 μg/mL. Aliquot to avoid repeated freeze-thaw cycles. |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Lyophilized powder: Store at −25 to −15°C; stable for 1 year upon receipt.
Reconstituted protein: Store under sterile conditions at −85 to −65°C; stable for 3 months.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.